1. Compared to standard therapy, patients in the lopinavir-ritonavir treatment group did not show reductions in 28-day mortality and progression ...
1. Compared to standard therapy, patients in the lopinavir-ritonavir treatment group did not show reductions in 28-day mortality and progression ...
1. In this randomized controlled trial involving adults hospitalized with confirmed SARS-CoV-2 infection, treatment with lopinavir-ritonavir in addition to standard ...
1. This randomized controlled trial showed that prophylaxis with lopinavir-ritonavir was not superior to lamivudine in preventing HIV infections through breastfeeding ...
